Ionis Pharmaceuticals, Inc. · NASDAQ:IONS

Loscalzo Joseph sold 77,289 Ionis Pharmaceuticals, Inc. shares (Form 4)

Traded May 4, 2026 · Filed May 6, 2026

On May 4, 2026, Loscalzo Joseph (Director) sold 77,289 Ionis Pharmaceuticals, Inc. shares at an average US$75.06 for US$5.8M under a trading plan, leaving 36,330 shares. Filed May 6, 2026 (Form 4).

Sold
77,289 shares
Price
US$75.06 average (US$74.90 to US$75.58)
Value
US$5.8M
Holding after
36,330 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 4, 2026Common StockOption exercise10,968US$38.0647,298Direct
May 4, 2026Common StockOption exercise12,000US$40.0559,298Direct
May 4, 2026Common StockOption exercise10,321US$41.0869,619Direct
May 4, 2026Common StockOption exercise16,000US$42.8885,619Direct
May 4, 2026Common StockOption exercise12,000US$60.2097,619Direct
May 4, 2026Common StockOption exercise16,000US$64.80113,619Direct
May 4, 2026Common StockSale59,508US$74.9054,111Direct
May 4, 2026Common StockSale17,781US$75.5836,330Direct

Source

View original at SEC

Related